TransMedics Group Inc.

TransMedics Group Inc. is a commercial-stage medical technology company specializing in advanced systems and services for solid organ transplantation. Headquartered in Andover, Massachusetts, it focuses on improving the preservation, assessment, and transport of donor hearts, lungs, and livers for patients with end-stage organ failure. The company’s core platform, the Organ Care System, is a portable normothermic perfusion technology that keeps donor organs functioning in a near-physiologic state outside the body, enabling clinicians to evaluate and optimize organ quality prior to transplant. TransMedics combines this device platform with a service-led model that includes its National OCS Program, offering end-to-end organ retrieval, clinical management, logistics coordination, and dedicated transportation for transplant centers across the United States. Operating in the high-acuity transplant ecosystem, TransMedics plays a critical role in organ transplant workflows by helping transplant programs increase organ utilization and support complex heart, lung, and liver procedures through integrated technology and clinical services.

Want to understand how we rate dividend safety? Read our full methodology